Andrew Singleton, PhD
Laboratory of Neurogenetics
National Institute on Aging/NIH
Dr Singleton received his BSc from the University of Sunderland, UK and his PhD from the University of Newcastle upon Tyne. His postdoctoral studies were undertaken at the Mayo Clinic in Jacksonville, Florida. Dr Singleton moved to the National Institute on Aging at NIH in Bethesda, Maryland in 2001. In 2007, Dr Singleton became a tenured senior investigator at the National Institute on Aging. Dr. Singleton’s laboratory works on the genetic basis of neurological disorders. Dr Singleton currently serves on the scientific advisory boards of the Michael J. Fox Foundation, the Dystonia Medical Research Foundation and the Lewy Body Dementia Association; he is a member of the editorial boards of Neurodegenerative Diseases, Neurogenetics and Annals of Neurology. Dr. Singleton was awarded the Boehringer Mannheim Research Award in 2005 and in 2008 was awarded the NIH Director's Award and the Annemarie Opprecht Award for his work on Parkinson's disease genetics.